Disease proteomics

Nature

Volumn 422, Issue 6928, 2003, Pages 226-232

  Hanash, Sam ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMARKERS; DISEASES; GENES; THROUGHPUT;

DISEASE PROTEOMICS;

PROTEINS;

GENOME;

AMINO ACID SEQUENCE; DISEASE ACTIVITY; DISEASE COURSE; DNA MICROARRAY; DRUG ACTIVITY; DRUG MECHANISM; DRUG TARGETING; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

DISEASE; DRUG DESIGN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ARRAY ANALYSIS; PROTEOME; PROTEOMICS;

EID: 0037434981     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01514     Document Type: Review

References (59)

1. Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C. & Liotta, L. A. Clinical proteomics: translating benchside promise into bedside reality. Nature Rev. Drug Discov. 1, 683-695 (2002).
2. Hanash, S. 2-D or not 2-D - is there a future for 2-D gels in proteomics? Insights from York proteomic meeting. Proteomics 1, 635-637 (2001).
3. Hanash, S. M., Madoz-Gurpide, J. & Misek, D. E. Identification of novel targets for cancer therapy using expression proteomics. Leukemia 16, 478-485 (2002).
4. Van Eyk, J. E. Proteomics: unraveling the complexity of heart disease and striving to change cardiology. Curr. Opin. Mol. Therapeut. 3, 546-553 (2001).
5. Li, X. P. et al. A two-dimensional gel electrophoresis database of rat heart protein. Electrophoresis 20, 891-897 (1999).
6. Evans, G., Wheeler, C. H., Corbett, J. M. & Dunn, M. J. Construction of HSC-2D PAGE: a two-dimensional gel electrophoresis database of heart proteins. Electrophoresis 18, 471-479 (1997).
7. van Der Velden, J. et al. Effects of calcium, inorganic, phosphate, and pH on isometric force in single skinned cardiomyocytes from donor and failing human hearts. Circulation 104, 1140-1146 (2001).
8. Arrell, D. K., Neverova, I., Fraser, H., Marbán, E. & Van Eyk, J. E. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain I. Circ. Res. 89, 480-487 (2001).
9. Ping, P., Zhang, J., Pierce, W. M. & Bolli, R. Functional proteomic analysis of protein kinase Cε signaling complexes in the normal heart and during cardioprotection. Circ. Res. 88, 59-62 (2001).
10. Heinke, M. Y. et al. Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis 19, 2021-2030 (1998).
11. Westbrook, J. A., Yan, J. X., Wait, R., Welson, S. Y. & Dunn, M. J. Zooming-in on the proteome: very narrow-range immobilized pH gradients reveal more protein species and isoforms. Electrophoresis 22, 2865-2871 (2001).
12. Hoving, S. et al. Preparative two-dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradients. Proteomics 2, 127-134 (2002).
13. Langen, H. et al. Two-dimensional map of the proteome of Haemophilus influenzae. Electrophoresis 21, 411-429 (2000).
14. Zuo, X. & Speicher, D. W. Comprehensive analysis of complex proteomes using microscale solution isoelectrofocusing prior to narrow pH range two-dimensional electrophoresis. Proteomics 2, 58-68 (2002).
15. Patton, W.F. Detection technologies in proteome analysis. J. Chomatogr. B771, 3-31 (2002).
16. Zhou, G. et al. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Peoteomics 1, 117-124 (2001).
17. Gagnon, E. et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110, 119-131 (2002).
18. Sabarth, N. et al. Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two dimensional gel electrophoresis. J. Biol. Chem. 277, 27896-27902 (2002).
19. Shin, B. K. et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J. Biol. Chem. DOI: 10.1074/jbc.M210455200 (2002).
20. Brivio, M. et al. Integrated microfluidic system enabling (bio)chemical reactions with on-line MALDI-TOF mass spectrometry. Anal. Chem. 74, 3972-3976 (2002).
21. Stoeckli, M., Chaurand, P., Hallaban, D. E. & Caprioli, R. M. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nature Med. 7, 493-496 (2001).
22. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
23. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869-10874 (2001).
24. Brenton, J. D., Aparicio, S. A. & Caldas, C. Molecular profiling of breast cancer: portraits but not physiognomy. Breast Cancer Res. 3, 77-80 (2001).
25. Gruvberger, S. et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 61, 5979-5984 (2001).
26. van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009 (2002).
27. Chen, G. et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 8, 2290-2305 (2002).
28. Opinion. Microarray standards at last. Nature 419, 323 (2002).
29. Pellois J. P. et al. Individually addressable parallel peptide synthesis on microchips. Nature Biotechnol. 20, 922-926 (2002).
30. Knezevic, V. et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1, 1271-1278 (2001).
31. Paweletz, C. P. et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981-1989 (2001).
32. Robinson, W. H. et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nature Med. 8, 295-301 (2002).
33. Madoz-Gurpide, J., Wang, H., Misek, D. E., Brichory, F. & Hanash, S. M. Protein based microarrays: a tool for probing the proteome of cancer cells and tissues. Proteomics 1, 1270-1287 (2001).
34. Zhang, L. et al. Contribution of human α-defensin 1, 2 and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298, 995-1000 (2002).
35. Hanash, S. Harnessing immunity for cancer marker discovery. Nature Biotechnol. 21, 37-38 (2003).
36. Stockert, E. et al. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med. 187, 1349-1354 (1998).
37. Gourevitch, M. M. et al. Polymorphic epithelial mucin (MUC1)-containing circulating immune complexes in carcinoma patients. Br. J. Cancer 72, 934-938 (1995).
38. Gure, A. O. et al. Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res. 58, 1034-1341 (1998).
39. Yamamoto, A., Shimizu, E., Ogura, T. & Sone, S. Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients. Int. J. Cancer 22, 283-289 (1996).
40. Soussi, T. The humoral response to the tumor-suppressor gene product p53 in human cancer: implications for diagnosis and therapy. Immunol. Today 17, 354-356 (1996).
41. Old, L. J. & Chen, Y. T. New paths in human cancer serology. J. Exp. Med. 187, 1163-1167 (1998).
42. Mintz, P. J. et al. Fingerprinting the circulating repertoire cancer patients. Nature Biotechnol. 21, 57-63 (2003).
43. Le Naour, F. Contribution of proteomics to tumor immunology. Proteomics 1, 1295-1302 (2001).
44. Brichory, F. M. et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl. Acad. Sci. USA 98, 9824-9829 (2001).
45. Vondriska, T. M. & Ping, P. Functional proteomics to study protection of the ischaemic myocardium. Expert Opin. Therapeut. Targets 6, 563-570 (2002).
46. Borodovsky, A. et al. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem. Biol. 9, 1149-1159 (2002).
47. Jessani, N., Liu, Y., Humphrey, M. & Cravatt, B. F. Enzyme activety profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc. Natl. Acad. Sci. USA 99, 10335-10340 (2002).
48. Greenbaum, D. et al. Chemical approaches for functionally probing the proteome. Mol. Cell. Proteomics 1, 60-68 (2002).
49. Rubenwolf, S. et al. Functional proteomics using chromophore-assisted laser inactivation. Proteomics. Proteomics 2, 241-246 (2002).
50. VanBogelen, R. A., Schiller, E. E., Thomas, R. D. & Neidhardt, F. C. Diagnosis of cellular states of microbial organisms using proteomics. Eletrophoresis 20, 2149-2159 (1999).
51. Lasonder, E. et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 419, 537-542 (2002).
52. Florens, L. et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 419, 520-526 (2002).
53. Nilsson, C. L. Bacterial proteomics and vaccine development. Am. J. Pharmacogenomics 2, 59-65 (2002).
54. Eymann, C., Homuth, G., Scharf, C. & Hecker, M. Bacillus subtilis functional genomics: global characterization of the stringent response by proteome and transcriptome analysis. J. Bacteriol. 184, 2500-2520 (2002).
55. Haas, G. et al. Immunoproteomic of Helicobacter pylori infection and relation to gastric disease. Proteomics 2, 313-324 (2002).
56. Reid, S. D. et al. Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response. J. Bacteriol. 184, 6316-6324 (2002).
57. Antelmann, H., Yamamoto, H., Sekiguchi, J. & Hecker, M. Stabilization of cell wall proteins in Bacillus Subtilis: a proteomic approach. Proteomics 2, 591-602 (2002).
58. Lewis, T. S. et al. Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry. Mol. Cell 6, 1343-1354 (2000).
59. McKerrow, J. H. et al. A functional proteomics screen of proteases in colorectal carcinoma. Mol. Med 6, 450-460 (2000).